These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33547737)

  • 21. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats.
    Mosti MP; Stunes AK; Ericsson M; Pullisaar H; Reseland JE; Shabestari M; Eriksen EF; Syversen U
    Endocrinology; 2014 Jun; 155(6):2178-89. PubMed ID: 24708238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doping control analysis of 121 prohibited substances in equine hair by liquid chromatography-tandem mass spectrometry.
    Wong JKY; Choi TLS; Kwok KY; Lei ENY; Wan TSM
    J Pharm Biomed Anal; 2018 Sep; 158():189-203. PubMed ID: 29885604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach.
    Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM
    J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Hypoxia-inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control.
    Mathew B; Philip M; Perwad Z; Karatt TK; Caveney MR; Subhahar MB; Karakka Kal AK
    Drug Test Anal; 2021 Jun; 13(6):1203-1215. PubMed ID: 33569900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance.
    Scarth JP; Spencer HA; Timbers SE; Hudson SC; Hillyer LL
    Drug Test Anal; 2010 Jan; 2(1):1-10. PubMed ID: 20878880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control.
    Fenwick SJ; Scarth JP
    Drug Test Anal; 2011 Oct; 3(10):705-16. PubMed ID: 21916022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
    Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
    Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high-throughput and broad-spectrum screening method for analysing over 120 drugs in horse urine using liquid chromatography-high-resolution mass spectrometry.
    Wong JKY; Chan GHM; Choi TLS; Kwok KY; Lau MY; Leung GNW; Wan TSM; Ho ENM
    Drug Test Anal; 2020 Jul; 12(7):900-917. PubMed ID: 32267632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of inorganic cobalt and a vitamin B
    Hillyer LL; Ridd Z; Fenwick S; Hincks P; Paine SW
    Equine Vet J; 2018 May; 50(3):343-349. PubMed ID: 29053883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a place for hair analysis in doping controls?
    Rivier L
    Forensic Sci Int; 2000 Jan; 107(1-3):309-23. PubMed ID: 10689583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.
    Bovee TF; Blokland M; Kersten S; Hamers AR; Heskamp HH; Essers ML; Nielen MW; van Ginkel LA
    Anal Bioanal Chem; 2014 Jan; 406(3):705-13. PubMed ID: 24287635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice.
    Chen W; Gao R; Xie X; Zheng Z; Li H; Li S; Dong F; Wang L
    Sci Rep; 2015 May; 5():9884. PubMed ID: 25943561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doping detection in animals: A review of analytical methodologies published from 1990 to 2019.
    Moreira F; Carmo H; Guedes de Pinho P; Bastos ML
    Drug Test Anal; 2021 Mar; 13(3):474-504. PubMed ID: 33440053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
    Han JK; Kim HL; Jeon KH; Choi YE; Lee HS; Kwon YW; Jang JJ; Cho HJ; Kang HJ; Oh BH; Park YB; Kim HS
    Eur Heart J; 2013 Jun; 34(23):1755-65. PubMed ID: 21920965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis.
    Thevis M; Thomas A; Kohler M; Beuck S; Möller I; Schäfer M; Rodchenkov G; Yin S; Loo JA; Geyer H; Schänzer W
    Eur J Mass Spectrom (Chichester); 2010; 16(3):301-12. PubMed ID: 20530837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection, quantification, and identification of dermorphin in equine plasma and urine by LC-MS/MS for doping control.
    Guan F; Uboh CE; Soma LR; Robinson M; Maylin GA; Li X
    Anal Bioanal Chem; 2013 May; 405(14):4707-17. PubMed ID: 23571464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking main environmental factors masking a minor steroidal doping effect using metabolomic analysis of horse urine by liquid chromatography-high-resolution mass spectrometry.
    Stojiljkovic N; Leroux F; Bubanj S; Popot MA; Paris A; Tabet JC; Junot C
    Eur J Mass Spectrom (Chichester); 2019 Jun; 25(3):339-353. PubMed ID: 31096786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
    Han S; Ritzenthaler JD; Zheng Y; Roman J
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
    Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
    Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.